Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725

Inflammation in atherosclerosis

Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129

CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein

Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996

Atherosclerosis

Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574

Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens

Nilsson, J. Å., & Shah, P. K. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.08.033 · Cited by 8

Multiple Signaling Molecules are Involved in Expression of CCL2 and IL-1β in Response to FSL-1, a Toll-Like Receptor 6 Agonist, in Macrophages

Won, K., Kim, S., Lee, S.-A., Rhim, B.-Y., Eo, S. K., & Kim, K. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.6.447 · Cited by 8

2011 Nobel Prize in Physiology or Medicine

Tedgui, A., Owens, A. P., & Mackman, N. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240432 · Cited by 8

Is Toll-like receptor responsiveness a marker and predictor of coronary artery disease?

Björkbacka, H. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.032 · Cited by 7

TLR4 as a possible key regulator of pathological vascular remodeling by Ang II receptor activation

Tamura, K., Kanaoka, T., Kobayashi, R., Ohki, K., & Ohsawa, M. (2015) · Hypertension Research · doi:10.1038/hr.2015.65 · Cited by 7

Pycnogenol Reduces Toll-Like Receptor 4 Signaling Pathway-Mediated Atherosclerosis Formation in Apolipoprotein E-Deficient Mice

Liu, R., Fan, B., Cong, H., Ikuyama, S., Guan, H., & Gu, J. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000415 · Cited by 7

Association of proinflammatory genes expression with serum interleukin 1β and free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study

Amiri, P., Baradaran, B., Saghafi‐Asl, M., Naghizadeh, M., Shanehbandi, D., Karamzad, N., & Vahed, S. Z. (2019) · BMC Immunology · doi:10.1186/s12865-019-0303-2 · Cited by 7

Identification of molecular subtypes of coronary artery disease based on ferroptosis- and necroptosis-related genes

Liu, W.-P., Li, P., Zhan, X., Qu, L., Xiong, T., Hou, F.-F., Wang, J.-K., Wei, N., & Liu, F.-Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.870222 · Cited by 9

Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2

Liao, D., Su, X., Wang, J., Yu, J., Luo, H., Tian, W., Ye, Z., & He, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113715 · Cited by 7

TRIF is a regulator of TLR2-induced foam cell formation

Huang, B., Park, D., & Baek, S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5647 · Cited by 7

Mikrobiom, Diabetes und Herz: neue Zusammenhänge?

Kappel, B. A., & Lehrke, M. (2019) · Herz · doi:10.1007/s00059-019-4791-x · Cited by 8

Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4

Shokri, M., Bagheri, B., Garjani, A., Sohrabi, B., Habibzadeh, A., Kazemi, B., & Movassaghpour, A. A. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.087 · Cited by 7

Innate immunity meets arteriogenesis: The versatility of toll-like receptors

Monaco, C. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.015 · Cited by 7

Toll-like Receptor 4 and Vascular Cell Adhesion Molecule 1 in Monocyte-Endothelium Adhesion Induced by Lipopolysaccharide

Hung, C.-H., Wu, D., Lin, F.-Y., Yuan, R.-Y., & Hu, C. J. (2010) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2010.10.003 · Cited by 6

Toll in the vessel wall—for better or worse?

Hansson, G. K., & Lundberg, A. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019722108 · Cited by 6

Sulfated Galactofucan from Sargassum Thunbergii Attenuates Atherosclerosis by Suppressing Inflammation Via the TLR4/MyD88/NF-κB Signaling Pathway

Zhu, K.-F., Wang, X., Weng, Y., Mao, G., Bao, Y., Lou, J., Wu, S., Jin, W., & Tang, L. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-022-07383-3 · Cited by 6

Targeting innate immunity for CV benefit

Moore, K. J., & Freeman, M. W. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.05.007 · Cited by 6

The Role of RP105 in Cardiovascular Disease through Regulating TLR4 and PI3K Signaling Pathways

Yang, J. M., Zeng, P., Yang, J., & Fan, Z. (2019) · Current Medical Science · doi:10.1007/s11596-019-2017-3 · Cited by 6

Innate Immunity in Atherosclerosis

Björkbacka, H., & Nilsson, J. (2010) · Journal of Innate Immunity · doi:10.1159/000314770 · Cited by 6

Heart failure--definition and diagnosis.

Ramakrishnan, S., Ss, K., & Vk, B. (2005) · PubMed · Cited by 6

Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances

Chahkand, M. S. G., Tavakoli, Y., Aghakhani, A., Askarzadeh, M., Azimi, H., Ghalamkarpour, N., Alizadeh, A., Archin, I., Kermani, S., Ansari, A., et al. (2024) · Turkish Journal of Immunology · doi:10.4274/tji.galenos.2024.26213 · Cited by 5

Environmental modulators of vascular physiology and inflammation

Seneviratne, A. N., Majumdar, A., Surendranath, K., & Miller, M. R. (2025) · Experimental Physiology · doi:10.1113/ep092309 · Cited by 5

Deciphering the Role of CD36 in Gestational Diabetes Mellitus: Linking Fatty Acid Metabolism and Inflammation in Disease Pathogenesis

Huang, L., Zhang, T., Zhu, Y., Lai, X., Tao, H., Xing, Y., & Li, Z. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s502314 · Cited by 5

Myocardial Expression of Pluripotency, Longevity, and Proinflammatory Genes in the Context of Hypercholesterolemia and Statin Treatment

Mylonas, K. S., Peroulis, M., Kapetanakis, E. I., & Kapelouzou, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071994 · Cited by 5

Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice

Okamoto, R., Gery, S., Gombart, A. F., Wang, X., Castellani, L. W., Akagi, T., Chen, S., Arditi, M., Ho, Q. H., Lusis, A. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085341 · Cited by 5

Association of monoctye expression of Toll-like receptor 4 and its related cytokines with coronary luminal stenosis

Bagheri, B., Sohrabi, B., Movassaghpur, A., Mashayekhi, S. O., Garjani, A., Shokri, M., Noori, M., & Garjani, A. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.47a1004 · Cited by 5

Immune regulatory cells: circulating biomarker factories in cardiovascular disease

Pasterkamp, G., Versteeg, D., & de Kleijn, D. P. V. (2008) · Clinical Science · doi:10.1042/cs20080089 · Cited by 5

The Involvement of Toll-like Receptor-2 in Arterial Thrombus Formation

Reinhardt, C. (2018) · Hämostaseologie · doi:10.1055/s-0038-1668164 · Cited by 5

Lipopolysaccharide, CD14 and Toll-like Receptors: an Emerging Link Between Innate Immunity and Atherosclerotic Disease

Shimada, K., Daida, H., Ma-Krupa, W., Goronzy, J. J., & Weyand, C. M. (2005) · Future Cardiology · doi:10.2217/14796678.1.5.657 · Cited by 5

El monocito/macrófago como diana terapéutica en la aterosclerosis

Pou, J., Rebollo, A., & Alegret, M. (2007) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(07)74180-3 · Cited by 5

Oat fiber attenuates circulating oxysterols levels and hepatic inflammation via targeting TLR4 signal pathway in LDL receptor knockout mice

Gao, H., Rao, C. H., Song, R., & Han, S. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104322 · Cited by 5

The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients

Megahed, F. A. K., Zhou, X., Sun, P., & Elmaghrabi, M. M. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00084-w · Cited by 5

Suppression of TRIF-dependent signaling pathway of Toll-like receptors by oak wood vinegar in RAW264.7 macrophages

Park, S., Lee, A.-N., Back, S.-K., & Youn, H. (2010) · Molecular & Cellular Toxicology · doi:10.1007/s13273-010-0010-9 · Cited by 5

Delivery strategies of melanoma vaccines: an overview

Lai, Y. H., & Wang, C. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.979 · Cited by 5

Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date

Nelson, C. P., & Erridge, C. (2018) · Immunogenetics · doi:10.1007/s00251-018-1092-0 · Cited by 5

Oxidized Phospholipid Inhibition of LPS-Signaling

Erridge, C. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181909 · Cited by 5

Coronary plaque vulnerability in statin-treated patients with elevated LDL-C and hs-CRP: optical coherence tomography study

Chamaria, S., Ueyama, H. A., Yasumura, K., Johnson, K. W., Vengrenyuk, Y., Okamoto, N., Barman, N., Bhatheja, S., Kapur, V., Hasan, C. M., et al. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-021-02238-8 · Cited by 4

Systemic inflammation in psoriasis: Sequel of metabolic syndrome

Dutta, D., Maisnam, I., Mukhopadhyay, S., Raychaudhuri, S. K., & Raychaudhuri, S. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00027-x · Cited by 4

The effect and mechanism of inulin on atherosclerosis is mediated by the characteristic intestinal flora and metabolites

Li, Z., Xu, Q., Huangfu, N., & Cui, H. (2024) · Coronary Artery Disease · doi:10.1097/mca.0000000000001377 · Cited by 4

Role of diet in development of non-communicable diseases: focus on gut microbiome

Fričová, A., Zavaďáková, A., & Bludovská, M. (2024) · Central European Journal of Public Health · doi:10.21101/cejph.a8138 · Cited by 4

Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation

Mylonas, K. S., Peroulis, M., & Kapelouzou, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115866 · Cited by 4

Regulating Inflammation in the Heart

Fairweather, D. (2007) · International Journal of Biomedical Science · doi:10.59566/ijbs.2007.3009 · Cited by 4

Vascular Endothelial Responses to Disturbed Flow: Pathologic Implications for Atherosclerosis

Chiu, J., Usami, S., & Chien, S. (2008) · Springer eBooks · doi:10.1007/978-3-540-75409-1_19 · Cited by 4

Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathway

Bustamante‐Munguira, J., Tamayo, E., & Herreros (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s33416 · Cited by 4

Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque.

Trusca, V. G., Fuior, E. V., & Gafencu, A. V. (2015) · Current Molecular Medicine · doi:10.2174/1566524016666151123110310 · Cited by 4

Lipoprotein Oxidation and Modification

Miller, Y. I., & Tsimikas, S. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50012-3 · Cited by 4

Probiotic Species on Cardiovascular Disease

Chen, H., & Konhilas, J. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-396485-4.00017-7 · Cited by 4

Atherosclerosis

Toh, B., Kyaw, T. S., Tipping, P. G., & Bobik, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00071-x · Cited by 4

Brazilin inhibits the inflammatory immune response induced by LPS in THP-1 cellsPreprint

Han, D., Ma, T., Sun, S., Zhang, Y., & Song, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2727104/v1 · Cited by 4

Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting

Zhu, Z., Xu, R., Zheng, X., Wang, T., Li, D., Wang, Y., & Liu, K. (2016) · Vascular and Endovascular Surgery · doi:10.1177/1538574416670308 · Cited by 3

Gut Microbiome in Dyslipidemia and Atherosclerosis

Puetz, A., & Kappel, B. A. (2023) · Endocrinology · doi:10.1007/978-3-031-08115-6_10-1 · Cited by 3

Circulating anti-β 2 -glycoprotein I antibodies of peripheral arterial disease patients trigger a genomic overexpression of Toll-like receptor 4 in endothelial cells

Varela, C., Haro, J. D., Bleda, S., Rodríguez-Padilla, J., Ferruelo, A., & Acín, F. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.11.066 · Cited by 3

Genetics of Atherosclerotic Cardiovascular Disease

Qasim, A., & Reilly, M. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00061-6 · Cited by 4

Genome-wide analysis of differentially expressed long noncoding RNAs induced by low shear stress in human umbilical vein endothelial cells

Chen, S., Wang, Z., Hu, Z., & Li, B. (2015) · Integrative Molecular Medicine · doi:10.15761/imm.1000154 · Cited by 3

Association of coronary artery disease with toll-like receptor 4 genetic variants: A meta-analysis

Sheng, J., & Xu, J. F. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/91791 · Cited by 3

Drug-gut Microbiome Interaction in Atherosclerosis Therapeutics

Zhang, H.-J., Wang, Y., & Jiang, J. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230410094806 · Cited by 3

Immune regulation in atherosclerosis and the hygiene hypothesis

Ait‐Oufella, H., Tedgui, A., & Mallat, Z. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_12 · Cited by 3

Molecular Cell Biology of Atherosclerosis

Hansson, G. K. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_6-1 · Cited by 3

MD-2 as a possible therapeutic target for atherosclerosis

Chen, S., & Crother, T. R. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102760 · Cited by 3

The Significance of Toll-Like Receptors in the Development of Ischemic Damage

Skvortsova, V. I., Shurdumova, M. K., & Константинова, Е. В. (2011) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-011-9453-2 · Cited by 3

Quantitative Trait Loci and Candidate Genes for Neutrophil Recruitment in Sterile Inflammation Mapped in AXB-BXA Recombinant Inbred Mice

Cheng, Q., Seltzer, Z., Sima, C., Lakschevitz, F. S., & Glogauer, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124117 · Cited by 3

Impact of myeloid differentiation protein 1 on cardiovascular disease

Jiang, X., Ning, P., Yan, F., Wang, J., Cai, W., & Yang, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114000 · Cited by 3

Peptidoglycan in atherosclerotic plaque formation and vulnerability

Nijhuis, M. M. O. (2006) · Utrecht University Repository (Utrecht University) · Cited by 3

Immunomodulation and its effector mechanisms in atherosclerosis

Hjerpe, C. (2007) · Figshare · Cited by 3

The potential role of monocyte-lymphocyte interaction in arteriogenesis

Willems, S. (2009) · Utrecht University Repository (Utrecht University) · Cited by 3

Neutrophil elastase binds at the central domain of extracellular Toll-like receptor 4: AI prediction, docking, and validation in disease model

Ali, A., Gaba, L., Jetley, S., Khan, I. A., & Prakash, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-93511-6 · Cited by 2

MyD88-dependent signalling promotes the recruitment of fibrous cap smooth muscle cells in murine atherosclerosis

Gunnersen, S., Albarrán-Juárez, J., Jensen, L. F., Alonso-Herranz, L., Shim, J. T., Sørensen, C. B., & Bentzon, J. F. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120573 · Cited by 2

Elevated levels of apolipoprotein C3 impair platelet function and reduce thrombosis

Schrottmaier, W. C., Kral-Pointner, J. B., Mußbacher, M., Salzmann, M., Hochreiter, B., Pirabe, A., Reiter, T., Badrnya, S., Schmid, J. A., Volf, I., et al. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2026.01.004 · Cited by 2

Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy

Jiang, W., Tang, H., Hu, Y., Sun, J., Lou, Z., Qu, P., & Liu, Q. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2636761 · Cited by 2

Exercise training for the prevention and treatment of cardiometabolic disease

Kong, S., Foulkes, S., & Peters, A. E. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001288 · Cited by 2

Gut-derived bacterial extracellular vesicles: the microbial dark matter contributing to host inflammation and cardiometabolic disease

Oliver, B. A., Sun, M., Lee, Y. S., Cho, S., Zhu, T., Durgan, D. J., & Sweeney, G. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2672794 · Cited by 2

Bacterial Ghosts Modulation of Innate Immunity: Immune Responses During Chlamydia Infection

Stevens, M. (2015) · Atlanta University Center Robert W. Woodruff Library (Atlanta University Center Robert W. Woodruff Library) · Cited by 2

NF-κB — A Key Factor in Atherogenesis and Atheroprogression

Bonomini, F., Favero, G., & Rezzani, R. (2015) · InTech eBooks · doi:10.5772/61894 · Cited by 2

Role Of Toll Like Receptors In Various Diseases

Güven, B., & Can, M. (2012) · Sakarya Medical Journal · doi:10.5505/sakaryamj.2012.47550 · Cited by 2

Lack of IκBNS promotes cholate-containing high-fat diet-induced inflammation and atherogenesis in low-density lipoprotein (LDL) receptor-deficient mice

Kitamura, K., Isoda, K., Akita, K., Miyosawa, K., Kadoguchi, T., Shimada, K., & Daida, H. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.03.004 · Cited by 2

The Innate Immune Response Mediated by TLRs in Atherosclerosis

Chvez-Snchez, L., Chávez-Rueda, A. K., Legorreta-Haquet, M. V., Montoya-Díaz, E., & Blanco-Favela, F. A. (2012) · InTech eBooks · doi:10.5772/25632 · Cited by 2

Coplanar PCB-induced inflammation and dietary interventions

Eske, K. (2013) · UKnowledge (University of Kentucky) · Cited by 2

Future Potential Biomarkers for Postinterventional Restenosis and Accelerated Atherosclerosis

Karper, J. C., Ewing, M. M., Jukema, J. W., & Quax, P. H. A. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.11.107 · Cited by 2

Possible Pivotal Role of Latent Chronic T. gondii Infection in the Pathogenesis of Atherosclerosis

PRANDOTA, J. (2017) · Journal of Cardiology and Therapy · doi:10.17554/j.issn.2309-6861.2017.04.130 · Cited by 2

Association of Toll-like receptor 4 polymorphisms with the risk of coronary artery disease in the ethnic Zhuang population of the Guangxi Province of China

Huang, Z., Liu, Y., Liang, L., Liu, W., Sooranna, S. R., Mo, J., Liu, L., Li, Z., & Guo, J. (2019) · Gene · doi:10.1016/j.gene.2019.05.014 · Cited by 2

Antigen Candidates for Atherosclerosis Vaccine Development

Putri, D. K. S. C., Farabi, M. J. A., & Suryawan, I. G. R. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/441/1/012164 · Cited by 2

THE ROLE OF TOLL-LIKE RECEPTORS (TLR) IN THE PATHOGENESIS OF ATHEROSCLEROSIS

Chaulin, A. M., Grigoreva, Y. V., & Duplyakov, D. V. (2020) · International Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований) · doi:10.17513/mjpfi.13126 · Cited by 2

Introduction: Toll receptors come of age

Golenbock, D. T. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.012 · Cited by 2

Targeting the Toll-System in Cardiovascular Sciences

Földes, G., von Haehling, S., Jankowska, E. A., & Anker, S. D. (2007) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221307779815084 · Cited by 2

Treatment of T2DM-related inflammation and vascular injury by regulating cellular crosstalk in the islet microenvironment

Sun, A., Yang, H., Sun, J. Y., Luo, J., Zhou, L., Bao, T., Tong, X., Lin, Y., & Han, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1551853 · Cited by 1

Bifunctional glycolipids targeting TLR4·MD-2 and short pentraxins

Zucchetta, D., Nuschy, L., Gumpelmair, S., Steinberger, P., Wilson, I. B. H., Heine, H., & Zamyatina, A. (2026) · RSC Chemical Biology · doi:10.1039/d5cb00324e · Cited by 1

Costunolide, a Sesquiterpene Lactone, Protects Against Platelet Activation and Thrombus Formation

Sheu, J., Lin, K., Chen, R.-J., Chia, H.-P., Chen, T.-Y., Jayakumar, T., Wang, H.-H., Peng, H., Li, J.-Y., & Lu, W. (2026) · Cells · doi:10.3390/cells15100938 · Cited by 1

Association between Toll-Like Receptor 4 Genetic Variants and Hyperlipidemia Risk in Palestinian Adults: A Case-Control Study

Al-Razem, F., Shehadeh, Y., Dandees, D., Al-Kubaje, S., Abo-Shakhdam, S., & Adm, M. (2026) · Journal Of Biochemical Technology · doi:10.51847/065skanhha · Cited by 1

MyD88 in myeloid cells drives angiotensin II-induced vascular inflammation, is associated with prevalent heart failure, and predicts all-cause mortality in arterial hypertension

Wild, S., Finger, S., Schulz, A., Aluia, M., Bravo, J., Kumar, R., Lagrange, J., Alanis‐Lobato, G., Randriamboavonjy, V., Wild, J., et al. (2026) · European Heart Journal Open · doi:10.1093/ehjopen/oeag031 · Cited by 1

CIRP Promotes Redox-Inflammatory Endothelial Injury in High-Fat Diet-Fed ApoE−/− Mice and HUVECs: Involvement of TLR4/SIRT6 Signaling

Chen, D., Yang, J., Ren, L., Zheng, Z., Jin, Z., Gu, J., Zheng, N., Wang, W., He, J., & Lin, R. (2026) · Antioxidants · doi:10.3390/antiox15080943 · Cited by 1

Sterol Efflux by ABCA1 and ABCG1

Terasaka, N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-382171-3.10010-5 · Cited by 1

Host Pattern Recognition Receptors (Toll-Like Receptors, RIG-I-Like Receptors, NOD-Like Receptors) and Atherosclerosis

Feldmann, M., & Monaco, C. G. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_18 · Cited by 1

Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease

Nilsson, J. Å., Fredrikson, G. N., Chyu, K., Shah, P. K., & Björkbacka, H. (2006) · Future Lipidology · doi:10.2217/17460875.1.3.321 · Cited by 1

Role of the Immunological System in the Initiation and Progression of Atherosclerosis

Roche, L. D. (2010) · Cited by 1

Comparison of postprandial endotoxemia in male adolescents and male subjects above 50 years after a fat overload

Zaman, G. S., Zaman, F., & Rasul, M. G. (2014) · Cited by 1

Targeting TLR4/MAPKs signaling pathway: A better option for therapeutic inhibition of atherosclerosis

Ayyappan, J. P. (2014) · World Journal of Immunology · doi:10.5411/wji.v4.i2.116 · Cited by 1

Targeting vascular remodeling in abdominal aortic aneurysm : To identify novel treatment strategies and drug candidates

Vorkapić, E. (2016) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-127502 · Cited by 1

Molecular Biology and Genetics of Atherosclerosis

Hopkins, P. N. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00008-1 · Cited by 1

Atherosclerosis: An Age-Dependent Autoimmune Disease

Henderson, B. E., Rossmann, A., Cappellano, G., Jakic, B., Buszko, M., Mayerl, C., Wick, M. C., & Wick, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_53 · Cited by 1

Atherosclerosis: cell biology and lipoproteins

Wigren, M., & Björkbacka, H. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283353891 · Cited by 1

Protective Role for Toll-Like Receptor-9 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice

Koulis, C., Chen, Y., Hausding, C., Ahrens, I., Kyaw, T. S., Tay, C., Allen, T. J., Jandeleit-Dahm, K. A. M., Sweet, M. J., Akira, S., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302407 · Cited by 80

Platelet Factor 4 and Toll-Like Receptor 2 are Expressed in Atherosclerotic Plaques of Apolipoprotein E~(-/-)Mice

Hai, J. (2007) · Chinese Journal of Arteriosclerosis

Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis

Chen, S., Shimada, K., Crother, T. R., Erbay, E., Shah, P. K., & Arditi, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.072 · Cited by 32

Toll-like receptor signaling and atherosclerosis

Michelsen, K. S., & Arditi, M. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219662.88409.7c · Cited by 42

Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient Mice

Higashimori, M., Tatro, J. B., Moore, K. J., Mendelsohn, M. E., Galper, J., & Beasley, D. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.210971 · Cited by 125